US OptionsDetailed Quotes
COSM241220P2000
- 0.00
- 0.000.00%
15min DelayClose Nov 29 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest2.00Strike Price0.00Turnover0.00%IV-150.31%PremiumDec 20, 2024Expiry Date1.20Intrinsic Value100Multiplier19DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma0.69Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Cosmos Health Stock Discussion
Sign in to post a comment
$Cosmos Health (COSM.US)$
Cosmos Health Integrates Bitcoin and Ethereum as Treasury Reserve Assets
Cosmos Health (NASDAQ:COSM) has announced the integration of Bitcoin and Ethereum as part of its treasury reserve assets. This strategic move aligns with the company's investment in new technologies, following their recent acquisition of Cloudscreen, an AI-driven drug repurposing platform. The company aims to diversify its balance sheet through cryptocurrency and blockchain-related assets, ...
Cosmos Health Integrates Bitcoin and Ethereum as Treasury Reserve Assets
Cosmos Health (NASDAQ:COSM) has announced the integration of Bitcoin and Ethereum as part of its treasury reserve assets. This strategic move aligns with the company's investment in new technologies, following their recent acquisition of Cloudscreen, an AI-driven drug repurposing platform. The company aims to diversify its balance sheet through cryptocurrency and blockchain-related assets, ...
2
$Cosmos Health (COSM.US)$
Cosmos Health's Subsidiary CosmoFarm Achieves Record Revenue, Up 8.62% to $43 Million YTD 2024, with Gross Profit Rising 21%
Positive
Record revenue of $43 million YTD 2024, up 8.62% year-over-year
Gross profit increased by 21%
Projected to exceed $52 million in annualized revenue
Expanded customer base to over 1,500 pharmacies
Negative
None.
Cosmos Health's Subsidiary CosmoFarm Achieves Record Revenue, Up 8.62% to $43 Million YTD 2024, with Gross Profit Rising 21%
Positive
Record revenue of $43 million YTD 2024, up 8.62% year-over-year
Gross profit increased by 21%
Projected to exceed $52 million in annualized revenue
Expanded customer base to over 1,500 pharmacies
Negative
None.
2
$Cosmos Health (COSM.US)$
All the positive news and then this shit tanked! 😔
All the positive news and then this shit tanked! 😔
2
$Cosmos Health (COSM.US)$
Cosmos Health Reports Strong 160% Increase in 2024 YTD Sales on Amazon UK for Its Proprietary Brands
Cosmos Health Inc. (NASDAQ:COSM) has reported a significant 160% increase in sales of its proprietary brands on Amazon UK for the year-to-date 2024. Sales have risen to $596,000 from $230,000 during the same period in 2023. The company's CEO, Greg Siokas, expressed satisfaction with the strong reception of their brands in the UK market and anticipates continued growth...
Cosmos Health Reports Strong 160% Increase in 2024 YTD Sales on Amazon UK for Its Proprietary Brands
Cosmos Health Inc. (NASDAQ:COSM) has reported a significant 160% increase in sales of its proprietary brands on Amazon UK for the year-to-date 2024. Sales have risen to $596,000 from $230,000 during the same period in 2023. The company's CEO, Greg Siokas, expressed satisfaction with the strong reception of their brands in the UK market and anticipates continued growth...
6
$Cosmos Health (COSM.US)$
Cosmos Health Receives Initial Orders Exceeding $500,000 for C-Scrub in the UK; Future Orders Booked at Accelerated Pace with Strong Profitability Anticipated Due to High Profit Margins
Cosmos Health Receives Initial Orders Exceeding $500,000 for C-Scrub in the UK; Future Orders Booked at Accelerated Pace with Strong Profitability Anticipated Due to High Profit Margins
1
1
$Cosmos Health (COSM.US)$
Cosmos Health Expands Global Presence into India, a Market with Over 1.4Bn People, Through Exclusive Agreement to Distribute Virax Biolabs' Mpox PCR Detection Kits
Cosmos Health (NASDAQ:COSM) has entered an exclusive agreement with Virax Biolabs to distribute mpox virus real-time PCR detection kits across India, a market with over 1.4 billion people. This expansion follows a recent second reported case of mpox in India on September 18, 2024. The agreement positions C...
Cosmos Health Expands Global Presence into India, a Market with Over 1.4Bn People, Through Exclusive Agreement to Distribute Virax Biolabs' Mpox PCR Detection Kits
Cosmos Health (NASDAQ:COSM) has entered an exclusive agreement with Virax Biolabs to distribute mpox virus real-time PCR detection kits across India, a market with over 1.4 billion people. This expansion follows a recent second reported case of mpox in India on September 18, 2024. The agreement positions C...
1
$Cosmos Health (COSM.US)$
Cosmos Health Enters Development Phase for CCDL24, an Innovative Multitargeting Product for Gastrointestinal Disorders, with a Market Size Valued at Over $37.5 Billion
Cosmos Health (NASDAQ:COSM) has entered the development phase for CCDL24, an innovative treatment for gastrointestinal (GI) disorders. The product utilizes advanced biopolymeric grids from natural ingredients to encapsulate bioactive molecules, enhancing drug efficacy at targeted sites. Current efforts...
Cosmos Health Enters Development Phase for CCDL24, an Innovative Multitargeting Product for Gastrointestinal Disorders, with a Market Size Valued at Over $37.5 Billion
Cosmos Health (NASDAQ:COSM) has entered the development phase for CCDL24, an innovative treatment for gastrointestinal (GI) disorders. The product utilizes advanced biopolymeric grids from natural ingredients to encapsulate bioactive molecules, enhancing drug efficacy at targeted sites. Current efforts...
$Cosmos Health (COSM.US)$ If this can break past 1.05 then 1.08 to 1.09 is next stop
1
$Cosmos Health (COSM.US)$
Cosmos Health Secures Exclusivity Agreement with Virax Biolabs to Distribute mpox PCR Kits across the GCC, including the UAE, Saudi Arabia, Bahrain, Kuwait, Oman, and Qatar
Cosmos Health (NASDAQ:COSM) has expanded its exclusive distribution agreement with Virax Biolabs (NASDAQ:VRAX) to commercialize mpox virus real-time PCR detection kits in Gulf Cooperation Council (GCC) countries. This extension builds upon their previous agreement for Greece, Cyprus, and non-exclu...
Cosmos Health Secures Exclusivity Agreement with Virax Biolabs to Distribute mpox PCR Kits across the GCC, including the UAE, Saudi Arabia, Bahrain, Kuwait, Oman, and Qatar
Cosmos Health (NASDAQ:COSM) has expanded its exclusive distribution agreement with Virax Biolabs (NASDAQ:VRAX) to commercialize mpox virus real-time PCR detection kits in Gulf Cooperation Council (GCC) countries. This extension builds upon their previous agreement for Greece, Cyprus, and non-exclu...
2
No comment yet
73759284 : when is the reverse split?
Jaguar8 OP 73759284 : They are given 180 days to comply so no date yet